(Q35589681)

9 August 2017

1 reference

title

Newborn screening methods for cystic fibrosis (English)

1 reference

9 August 2017

0 references

Bridget Wilcken

1

1 reference

9 August 2017

Veronica Wiley

series ordinal

2

1 reference

9 August 2017

publication date

1 December 2003

1 reference

Paediatric Respiratory Reviews

9 August 2017

published in

1 reference

9 August 2017

volume

4

1 reference

9 August 2017

issue

4

1 reference

9 August 2017

page(s)

272-277

1 reference

Dried-blood spot screening for cystic fibrosis in the newborn

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal screening for cystic fibrosis in Wales and the West Midlands: clinical assessment after five years of screening

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Screening for cystic fibrosis in the newborn by meconium analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Screening for cystic fibrosis by a stool trypsin method

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Sensitive trypsin assay for dried-blood specimens as a screening procedure for early detection of cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Monoclonal antibody-based enzyme immunoassay for trypsinogen in neonatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Newborn screening for cystic fibrosis using an enzyme linked immunoabsorbent assay (ELISA) technique

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Europium as a label in time-resolved immunofluorometric assays

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

The neonatal detection of cystic fibrosis by measurement of immunoreactive trypsin in blood

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Variations in dried blood spot immunoreactive trypsin in relation to gestational age and during the first week of life

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Screening for cystic fibrosis: feasibility of molecular genetic analysis of dried blood specimens

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Analysis of 31 CFTR mutations by polymerase chain reaction/oligonucleotide ligation assay in a pilot screening of 4476 newborns for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal screening for cystic fibrosis: a comparison of two strategies for case detection in 1.2 million babies

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Comparison of two different protocols of neonatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal screening for cystic fibrosis in the Trent region (UK): two-stage immunoreactive trypsin screening compared with a three-stage protocol with DNA analysis as an intermediate step

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal screening for cystic fibrosis in Brittany, France: assessment of 10 years' experience and impact on prenatal diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal Screening for Cystic Fibrosis: Addition of Molecular Diagnostics to Increase Specificity

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experience.

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Cystic fibrosis: a worldwide analysis of CFTR mutations--correlation with incidence data and application to screening

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Identification of cystic fibrosis mutations in the United Arab Emirates. Mutations in brief no. 133. Online

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Intron-8 polythymidine sequence in Australasian individuals with CF mutations R117H and R117C

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

CFTR mutations and IVS8-5T variant in newborns with hypertrypsinaemia and normal sweat test

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Genetic counseling and neonatal screening for cystic fibrosis: an assessment of the communication process

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Newborn screening strategy for cystic fibrosis: a field study in an area with high allelic heterogeneity

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

Sweat testing following newborn screening for cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS1526-0542%2803%2900084-8

7 January 2021

10.1016/S1526-0542(03)00084-8

Identifiers

DOI

1 reference

9 August 2017

1 reference